PRESS FEATURE
Dr. Stephanie Venn-Watson: “Why good leaders make you feel safe”
Dr. Stephanie Venn-Watson is the CEO & Co-Founder of Seraphina Therapeutics, an emerging lifestyle brand bringing fatty15, the first-to-market science-backed, a once-daily dietary supplement containing the first essential first fatty acid to be discovered in 90 years, C15:0, to help consumers maximize the potential of healthy living with age. In addition to her role with fatty15, Stephanie is serial entrepreneur and veterinary epidemiologist who also successfully co-founded and launched Epitracker Inc., a therapeutics discovery company.